Monoclonal antibody production

Ended Purchase Order Awarded Last action

Contract number
75F40122P00547
Awardee
Awarding agency
Obligated
$34,122

Award facts

Opportunity
Contract value 38% obligated
  • $34,121.76 Current, with exercised options
  • $89,239.94 Potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Contracting staff
Set-aside
Total Small Business
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Beltsville, MD 20704, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00001 $17,313
Original award $16,809

About this award

The Food and Drug Administration awarded a purchase order to Kemp Proteins, LLC (doing business as Kempbio), a small disadvantaged business, for $89,239.94 on September 26, 2022. The order carries a total small business set-aside designation. Performance is located in Beltsville, Maryland, with work extending through September 29, 2027. The purchase order covers monoclonal antibody production services. The solicitation was posted September 1, 2022, with a due date of September 13, 2022.

Quick answers

Who was awarded contract 75F40122P00547?

75F40122P00547 was awarded to Kemp Proteins, LLC by Food and Drug Administration (Department of Health and Human Services) on September 26, 2022.

How much is contract 75F40122P00547 worth?

The government has obligated $34,122 on 75F40122P00547. Its potential value, with all options, is $89,240.

Was contract 75F40122P00547 competed?

The extent of competition for 75F40122P00547 was competed under sap. The government received 1 offer. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award